Baker Bros. Advisors as of June 30, 2020
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 114 positions in its portfolio as reported in the June 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Seattle Genetics | 35.4 | $8.0B | 47M | 169.92 | |
Incyte Corporation (INCY) | 14.7 | $3.3B | 32M | 103.97 | |
BeiGene Sponsored Adr (BGNE) | 9.8 | $2.2B | 12M | 188.40 | |
ACADIA Pharmaceuticals (ACAD) | 9.0 | $2.0B | 42M | 48.47 | |
Alexion Pharmaceuticals | 4.3 | $983M | 8.8M | 112.24 | |
BioMarin Pharmaceutical (BMRN) | 4.1 | $936M | 7.6M | 123.34 | |
Kodiak Sciences (KOD) | 2.8 | $626M | 12M | 54.12 | |
Ascendis Pharma A/S Sponsored Adr (ASND) | 2.2 | $501M | 3.4M | 147.90 | |
Invitae (NVTAQ) | 1.6 | $359M | 12M | 30.29 | |
Myokardia | 1.3 | $306M | 3.2M | 96.62 | |
Amarin Corporation Sponsored Adr (AMRN) | 1.1 | $239M | 35M | 6.92 | |
argenx SE Sponsored Adr (ARGX) | 1.0 | $230M | 1.0M | 225.23 | |
Igm Biosciences (IGMS) | 1.0 | $230M | 3.1M | 73.00 | |
Madrigal Pharmaceuticals (MDGL) | 0.7 | $170M | 1.5M | 113.25 | |
Mirati Therapeutics | 0.7 | $161M | 1.4M | 114.17 | |
EXACT Sciences Corporation (EXAS) | 0.7 | $161M | 1.8M | 86.94 | |
Neurocrine Biosciences (NBIX) | 0.5 | $111M | 907k | 122.00 | |
Principia Biopharma | 0.4 | $95M | 1.6M | 59.79 | |
Forma Therapeutics Holdings SHS | 0.4 | $93M | 2.0M | 46.49 | |
Cerus Corporation (CERS) | 0.4 | $91M | 14M | 6.60 | |
Heron Therapeutics (HRTX) | 0.4 | $89M | 6.0M | 14.71 | |
Insmed Incorporated Com Par $.01 (INSM) | 0.4 | $83M | 3.0M | 27.54 | |
Axsome Therapeutics (AXSM) | 0.4 | $83M | 1.0M | 82.28 | |
ADC Therapeutics SA SHS (ADCT) | 0.3 | $79M | 1.7M | 46.81 | |
Atreca Cl A Com (BCEL) | 0.3 | $75M | 3.5M | 21.28 | |
Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.3 | $71M | 2.8M | 25.48 | |
Adaptimmune Therapeutics Sponsored Adr (ADAP) | 0.3 | $67M | 6.7M | 10.01 | |
BioCryst Pharmaceuticals (BCRX) | 0.3 | $66M | 14M | 4.76 | |
DBV Technologies Sponsored Adr (DBVT) | 0.3 | $64M | 15M | 4.39 | |
Zymeworks | 0.3 | $62M | 1.7M | 36.07 | |
Rhythm Pharmaceuticals (RYTM) | 0.3 | $60M | 2.7M | 22.30 | |
Neoleukin Therapeutics | 0.2 | $56M | 3.4M | 16.60 | |
Chemocentryx | 0.2 | $54M | 945k | 57.54 | |
Allakos (ALLK) | 0.2 | $53M | 736k | 71.86 | |
Neurocrine Biosciences Note 2.25% 5/15/2024 (Principal) | 0.2 | $51M | 31M | 1.66 | |
Aeglea Biotherapeutics | 0.2 | $41M | 4.4M | 9.25 | |
Assembly Biosciences | 0.2 | $36M | 1.5M | 23.32 | |
Krystal Biotech (KRYS) | 0.1 | $34M | 818k | 41.42 | |
Protagonist Therapeutics (PTGX) | 0.1 | $34M | 1.9M | 17.66 | |
Merus N V (MRUS) | 0.1 | $33M | 2.0M | 16.09 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $29M | 897k | 32.66 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $28M | 1.7M | 16.25 | |
Alkermes SHS (ALKS) | 0.1 | $24M | 1.2M | 19.40 | |
GW Pharmaceuticals Ads | 0.1 | $23M | 185k | 122.72 | |
Altimmune (ALT) | 0.1 | $23M | 2.1M | 10.71 | |
Adaptive Biotechnologies Cor (ADPT) | 0.1 | $22M | 464k | 48.38 | |
Frequency Therapeutics | 0.1 | $22M | 946k | 23.25 | |
Tricida | 0.1 | $22M | 788k | 27.48 | |
Novavax (NVAX) | 0.1 | $20M | 241k | 83.35 | |
BioMarin Pharmaceutical Note 0.599% 8/1/2024 (Principal) | 0.1 | $18M | 15M | 1.22 | |
Bluebird Bio (BLUE) | 0.1 | $16M | 265k | 61.04 | |
Vaxart (VXRT) | 0.1 | $15M | 1.6M | 8.85 | |
Xencor (XNCR) | 0.1 | $14M | 428k | 32.39 | |
Immunomedics | 0.1 | $12M | 330k | 35.44 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $12M | 514k | 22.34 | |
Mirum Pharmaceuticals (MIRM) | 0.1 | $11M | 583k | 19.46 | |
Aimmune Therapeutics | 0.0 | $11M | 674k | 16.71 | |
Horizon Therapeutics Public SHS | 0.0 | $11M | 200k | 55.58 | |
uniQure SHS (QURE) | 0.0 | $10M | 231k | 45.06 | |
Xenon Pharmaceuticals (XENE) | 0.0 | $10M | 799k | 12.54 | |
Urovant Sciences SHS | 0.0 | $9.8M | 1.0M | 9.84 | |
Albireo Pharma | 0.0 | $9.8M | 369k | 26.49 | |
Karuna Therapeutics Ord | 0.0 | $9.1M | 82k | 111.46 | |
Fulgent Genetics (FLGT) | 0.0 | $9.1M | 569k | 16.00 | |
Sangamo Biosciences (SGMO) | 0.0 | $9.0M | 1000k | 8.96 | |
Reata Pharmaceuticals Cl A | 0.0 | $8.7M | 56k | 156.01 | |
Iveric Bio | 0.0 | $8.3M | 1.6M | 5.10 | |
Idera Pharmaceuticals Com Par | 0.0 | $8.3M | 4.6M | 1.79 | |
Hookipa Pharma Inc equity (HOOK) | 0.0 | $8.1M | 701k | 11.62 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $7.8M | 486k | 16.03 | |
Passage Bio (PASG) | 0.0 | $7.5M | 275k | 27.33 | |
Syros Pharmaceuticals | 0.0 | $7.4M | 690k | 10.66 | |
Cabaletta Bio (CABA) | 0.0 | $7.1M | 636k | 11.14 | |
Alector (ALEC) | 0.0 | $6.8M | 280k | 24.44 | |
Burning Rock Biotech Sponsored Ads (BNR) | 0.0 | $6.8M | 250k | 27.01 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $5.9M | 200k | 29.32 | |
Legend Biotech Corporation Sponsored Ads (LEGN) | 0.0 | $5.7M | 135k | 42.56 | |
Crinetics Pharmaceuticals In (CRNX) | 0.0 | $5.6M | 318k | 17.52 | |
Cymabay Therapeutics | 0.0 | $5.3M | 1.5M | 3.49 | |
Chiasma | 0.0 | $5.1M | 947k | 5.38 | |
Inflarx Nv (IFRX) | 0.0 | $4.9M | 1.1M | 4.59 | |
Abeona Therapeutics | 0.0 | $4.6M | 1.6M | 2.92 | |
Evofem Biosciences | 0.0 | $4.0M | 1.4M | 2.83 | |
Constellation Pharmceticls I | 0.0 | $4.0M | 133k | 30.05 | |
Ovid Therapeutics (OVID) | 0.0 | $3.4M | 458k | 7.37 | |
Kezar Life Sciences (KZR) | 0.0 | $3.1M | 600k | 5.18 | |
Viking Therapeutics (VKTX) | 0.0 | $3.1M | 425k | 7.21 | |
Gamida Cell SHS (GMDA) | 0.0 | $3.0M | 667k | 4.57 | |
Dicerna Pharmaceuticals | 0.0 | $3.0M | 119k | 25.40 | |
Arcus Biosciences Incorporated (RCUS) | 0.0 | $3.0M | 122k | 24.74 | |
Global Blood Therapeutics In | 0.0 | $3.0M | 47k | 63.13 | |
Aravive | 0.0 | $2.8M | 244k | 11.64 | |
Intellia Therapeutics (NTLA) | 0.0 | $2.7M | 129k | 21.02 | |
Galapagos NV Spon Adr (GLPG) | 0.0 | $2.6M | 13k | 197.29 | |
Acceleron Pharma | 0.0 | $2.6M | 27k | 95.26 | |
Denali Therapeutics (DNLI) | 0.0 | $2.5M | 105k | 24.18 | |
Ngm Biopharmaceuticals (NGM) | 0.0 | $2.5M | 124k | 19.74 | |
Orchard Therapeutics Ads | 0.0 | $2.4M | 406k | 6.00 | |
Applied Therapeutics (APLT) | 0.0 | $2.4M | 66k | 36.16 | |
ARYA Sciences Acquisition Corp. Shs Cl A | 0.0 | $2.4M | 150k | 15.74 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.0 | $2.3M | 500k | 4.62 | |
Molecular Templates | 0.0 | $2.2M | 158k | 13.79 | |
Oyster Point Pharma | 0.0 | $2.1M | 71k | 28.88 | |
Leap Therapeutics | 0.0 | $2.0M | 979k | 2.09 | |
Bellicum Pharmaceuticals | 0.0 | $1.9M | 249k | 7.43 | |
Matinas Biopharma Holdings, In (MTNB) | 0.0 | $1.6M | 2.1M | 0.77 | |
Galmed Pharmaceuticals SHS | 0.0 | $1.0M | 216k | 4.78 | |
Affimed Therapeutics B V | 0.0 | $923k | 200k | 4.62 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $525k | 580k | 0.90 | |
Marker Therapeutics Ord | 0.0 | $498k | 241k | 2.07 | |
Adamas Pharmaceuticals | 0.0 | $442k | 173k | 2.56 | |
Genfit SA Ads (GNFT) | 0.0 | $156k | 28k | 5.49 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $147k | 557k | 0.26 | |
Replimune Group (REPL) | 0.0 | $128k | 5.1k | 24.90 |